ERBB2 and neoplasm: Additionally, the treatment with EVs derived from HEK 293 cells loaded with a miR-21 inhibitor and coated with a Human Epidermal Growth Factor Receptor 2 (HER2) affibody decreased tumor growth via the activation of PTEN and the decreased resistance to 5-fluorouracil in colon cancer cells [135].